CD80 and cancer: Importantly, cancer cells can deliver Signal 1 to tumor-infiltrating lymphocytes (TILs) through MHC presentation of neoantigenic peptides yet are unable to deliver costimulatory Signal 2 because, like most epithelial cells, they typically lack expression of CD80 or CD86.